[go: up one dir, main page]

MX2009011408A - Metodo para estabilizar una proteina. - Google Patents

Metodo para estabilizar una proteina.

Info

Publication number
MX2009011408A
MX2009011408A MX2009011408A MX2009011408A MX2009011408A MX 2009011408 A MX2009011408 A MX 2009011408A MX 2009011408 A MX2009011408 A MX 2009011408A MX 2009011408 A MX2009011408 A MX 2009011408A MX 2009011408 A MX2009011408 A MX 2009011408A
Authority
MX
Mexico
Prior art keywords
stabilizing
container
protein
aqueous protein
protein solution
Prior art date
Application number
MX2009011408A
Other languages
English (en)
Inventor
Hanns-Christian Mahler
Astrid Pappenberger
Wolfgang Friess
Sylvia Kiese
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of MX2009011408A publication Critical patent/MX2009011408A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/05—Containers specially adapted for medical or pharmaceutical purposes for collecting, storing or administering blood, plasma or medical fluids ; Infusion or perfusion containers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/39591—Stabilisation, fragmentation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J3/00—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

La invención se refiere a un método para estabilizar una solución acuosa de proteína contra fuerza exógena que comprende la etapa de llenar un recipiente con la solución para que el recipiente carezca sustancialmente de un espacio de domos para gases cuando sea cerrado. Se proporciona también el uso de un recipiente para estabilizar una solución acuosa de proteína.
MX2009011408A 2007-05-02 2008-04-22 Metodo para estabilizar una proteina. MX2009011408A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP07107353 2007-05-02
PCT/EP2008/054835 WO2008135380A1 (en) 2007-05-02 2008-04-22 Method for stabilizing a protein

Publications (1)

Publication Number Publication Date
MX2009011408A true MX2009011408A (es) 2009-11-05

Family

ID=39674831

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2009011408A MX2009011408A (es) 2007-05-02 2008-04-22 Metodo para estabilizar una proteina.

Country Status (11)

Country Link
US (1) US7879976B2 (es)
EP (1) EP2144629A1 (es)
JP (1) JP2010524479A (es)
KR (1) KR101140483B1 (es)
CN (1) CN101674847A (es)
AU (1) AU2008248780B2 (es)
BR (1) BRPI0810710A2 (es)
CA (1) CA2685372A1 (es)
IL (1) IL201391A0 (es)
MX (1) MX2009011408A (es)
WO (1) WO2008135380A1 (es)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI1561756T1 (sl) 2002-09-11 2016-02-29 Chugai Seiyaku Kabushiki Kaisha Postopek čiščenja proteinov
EP2527364A1 (en) * 2007-03-29 2012-11-28 Abbott Laboratories Crystalline anti-human IL-12 antibodies
US8883146B2 (en) 2007-11-30 2014-11-11 Abbvie Inc. Protein formulations and methods of making same
GB0913773D0 (en) * 2009-08-07 2009-09-16 Isis Innovation Assay
EP2361636A1 (en) 2010-02-26 2011-08-31 CSL Behring AG Immunoglobulin preparation and storage system for an immunoglobulin preparation
MX344727B (es) 2010-11-11 2017-01-05 Abbvie Biotechnology Ltd Formulaciones liquidas de anticuerpos anti-tnf-alfa de alta concentracion mejoradas.
US8883979B2 (en) 2012-08-31 2014-11-11 Bayer Healthcare Llc Anti-prolactin receptor antibody formulations
MX2015003007A (es) 2012-09-07 2015-06-05 Coherus Biosciences Inc Formulaciones acuosas estables de adalimumab.
PE20160720A1 (es) * 2013-08-02 2016-07-28 Hoffmann La Roche Proteina de fusion terapeutica
LT3303396T (lt) 2015-05-29 2023-01-10 Bristol-Myers Squibb Company Antikūnai prieš ox40 ir jų panaudojimo būdai
IL302486A (en) 2015-06-24 2023-06-01 Hoffmann La Roche Antibodies against the transnephrine receptor with adapted affinity
AR106189A1 (es) * 2015-10-02 2017-12-20 Hoffmann La Roche ANTICUERPOS BIESPECÍFICOS CONTRA EL A-b HUMANO Y EL RECEPTOR DE TRANSFERRINA HUMANO Y MÉTODOS DE USO
JP6657392B2 (ja) 2015-10-02 2020-03-04 エフ・ホフマン−ラ・ロシュ・アクチェンゲゼルシャフト 二重特異性抗ヒトｃｄ２０／ヒトトランスフェリン受容体抗体及び使用方法
US11229702B1 (en) 2015-10-28 2022-01-25 Coherus Biosciences, Inc. High concentration formulations of adalimumab
WO2017184880A1 (en) * 2016-04-20 2017-10-26 Coherus Biosciences, Inc. A method of filling a container with no headspace
US11326182B2 (en) * 2016-04-29 2022-05-10 Voyager Therapeutics, Inc. Compositions for the treatment of disease
EP3852723B1 (en) 2018-09-20 2025-11-05 ACADIA Pharmaceuticals Inc. Stable intranasal formulations of carbetocin
AU2019345313A1 (en) 2018-09-20 2021-03-18 Levo Therapeutics, Inc. Carbetocin drug product and process for preparing same

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4666829A (en) * 1985-05-15 1987-05-19 University Of California Polypeptide marker for Alzheimer's disease and its use for diagnosis
US6001643A (en) * 1997-08-04 1999-12-14 C-Med Inc. Controlled hydrodynamic cell culture environment for three dimensional tissue growth
US7964192B1 (en) 1997-12-02 2011-06-21 Janssen Alzheimer Immunotherapy Prevention and treatment of amyloidgenic disease
AR038568A1 (es) 2002-02-20 2005-01-19 Hoffmann La Roche Anticuerpos anti-a beta y su uso
AU2003257536A1 (en) * 2002-08-27 2004-03-19 Chugai Seiyaku Kabushiki Kaisha Method of stabilizing protein solution preparation
FR2853551B1 (fr) * 2003-04-09 2006-08-04 Lab Francais Du Fractionnement Formulation stabilisante pour compositions d'immunoglobulines g sous forme liquide et sous forme lyophilisee
CN1780638B (zh) * 2003-05-23 2010-04-14 诺和诺德医疗保健公司 氧化硅涂层玻璃作为容器内壁材料的用途及以该材料作内壁的容器
AR046071A1 (es) 2003-07-10 2005-11-23 Hoffmann La Roche Anticuerpos contra el receptor i del factor de crecimiento de tipo insulinico y los usos de los mismos
EP1713502A1 (de) * 2004-02-12 2006-10-25 MERCK PATENT GmbH Hochkonzentrierte, flüssige formulierungen von anti-egfr-antikörpern
EP1755673B1 (en) * 2004-04-12 2014-07-23 MedImmune, LLC Anti-il-9 antibody formulations and uses thereof

Also Published As

Publication number Publication date
US20080275220A1 (en) 2008-11-06
CN101674847A (zh) 2010-03-17
US7879976B2 (en) 2011-02-01
IL201391A0 (en) 2010-05-31
EP2144629A1 (en) 2010-01-20
KR20090130867A (ko) 2009-12-24
WO2008135380A1 (en) 2008-11-13
CA2685372A1 (en) 2008-11-13
JP2010524479A (ja) 2010-07-22
AU2008248780A1 (en) 2008-11-13
BRPI0810710A2 (pt) 2014-10-21
KR101140483B1 (ko) 2012-07-11
AU2008248780B2 (en) 2013-01-31

Similar Documents

Publication Publication Date Title
MX2009011408A (es) Metodo para estabilizar una proteina.
WO2011051675A3 (en) Cement testing
MX2016005590A (es) Envases flexibles y metodos para su fabricacion.
EP2627438A4 (en) Integrated gas sparger for an immersed membrane
MX2013004381A (es) Dispositivo de bomba y metodos para hacer el mismo.
EP2411491A4 (en) PROCESS FOR THE PROCESSING OF NATURAL GAS WITH IMPROVED CO2 MANAGEMENT
MX336309B (es) Pipeta y punta de sellado.
EP4202555A3 (en) Developer supply container and developer supplying system
IN2015DN00399A (es)
UA109134C2 (ru) Устройство для инфузий, комплект, способ удерживания устройства для инфузий и переносной футляр для устройства для инфузий
MX2013001199A (es) Funda para un dispensador.
EP2596626B8 (en) Method for content presentation during trick mode operations
WO2012120344A3 (en) Fracturable container
GB2470760B (en) An improved process for characterising the evolution of an oil or gas reservoir over time
MX337549B (es) Derivados de insulina que contienen enlaces disulfuro adicionales.
MX2009001010A (es) Tapon de plastico con sobretapa, que incluye llave de tuerca y metodo.
IN2014DN05901A (es)
HUE045372T2 (hu) Eljárás lignin-tartalmú vizes oldat regenerálására
SG191057A1 (en) Inner frame with at least one creasing line, container containing same, use of such an inner frame blank and method for increasing stability of a container
GB2481444B (en) An improved process for characterising the evolution of an oil or gas reservoir over time
IL220604A0 (en) Combination, kit and method of reducing intraocular pressure
MX2012004392A (es) Llanta con fondo de surco asimetrico para surco del hombro.
EA201301314A1 (ru) Способ удаления свободного пространства над продуктом из наполненного контейнера и контейнер, содержащий клапан
MX2014007032A (es) Gel acuoso consumible para uso en control de pestes, dispositivo de control de pestes que comprenden un gel acuoso y el uso de un gel acuoso en un dispositivo de control de pestes y en un metodo de control de pestes.
WO2012019689A3 (de) Verwendung von hydroxypyridonen oder deren salzen zur stabilisierung von wasserstoffperoxid oder wasserstoffperoxid freisetzenden substanzen

Legal Events

Date Code Title Description
HH Correction or change in general
FG Grant or registration